LINC01888

Across TCGA pan-cancer cohorts, LINC01888 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01888 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01888 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01888 expression acts as an unfavorable survival marker, although some lineages such as CESC and MESO show a favorable association.

UVM, THYM, and STAD are the cancer types where LINC01888 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.355	0.813	<.001	102	view →
THYM	DFS	Quartile	All	0.513	0.938	.001	61	view →
STAD	DFS	Tertile	All	0.598	0.771	.011	51	view →
CESC	OS	Tertile	II,III,IV	0.931	0.779	.011	44	view →
LGG	OS	Tertile	All	0.704	0.838	<.001	27	view →
CHOL	OS	Quartile	All	0.517	0.922	.013	20	view →
MESO	DFS	Quartile	III,IV	0.615	0.322	.002	18	view →
GBM	OS	Tertile	All	0.249	0.499	.004	18	view →
LUAD	OS	Median	All	0.874	0.794	.012	14	view →
SARC	OS	Quartile	All	0.612	0.440	.011	9	view →
LUSC	DFS	Quartile	All	0.828	0.718	.016	8	view →
LIHC	OS	Tertile	All	0.629	0.727	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01888–UVM (DFS)

Open the UVM breakdown →